Fred Alger Management, LLC Biomarin Pharmaceutical Inc Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

A detailed history of Fred Alger Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 26,573 shares of BMRN stock, worth $1.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,573
Previous 29,516 9.97%
Holding current value
$1.77 Million
Previous $2.43 Million 23.17%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $203,125 - $276,171
-2,943 Reduced 9.97%
26,573 $1.87 Million
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $123,851 - $153,454
-1,664 Reduced 5.34%
29,516 $2.43 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $185,136 - $218,691
-2,209 Reduced 6.62%
31,180 $2.72 Million
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $571,116 - $738,135
-7,493 Reduced 18.33%
33,389 $3.22 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $571,245 - $634,433
-6,715 Reduced 14.11%
40,882 $3.62 Million
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $7.4 Million - $8.56 Million
-85,326 Reduced 64.19%
47,597 $4.13 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $5.29 Million - $7.07 Million
60,297 Added 83.02%
132,923 $12.9 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $2.75 Million - $3.69 Million
33,940 Added 87.73%
72,626 $7.52 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $2.69 Million - $3.17 Million
-32,718 Reduced 45.82%
38,686 $3.28 Million
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $3.67 Million - $4.46 Million
-51,391 Reduced 41.85%
71,404 $5.92 Million
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $6.91 Million - $8.63 Million
-93,055 Reduced 43.11%
122,795 $9.47 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $12.6 Million - $16 Million
174,998 Added 428.37%
215,850 $19.1 Million
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $201,953 - $230,854
2,701 Added 7.08%
40,852 $3.16 Million
Q2 2021

Aug 16, 2021
BUY
$75.51 - $84.79 $582,257 - $653,815
7,711 Added 25.33%
38,151 $3.18 Million
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $31.1 Million - $37.7 Million
-415,970 Reduced 93.18%
30,440 $2.3 Million
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $4.83 Million - $6 Million
66,567 Added 17.52%
446,410 $39.1 Million
Q3 2020

Nov 13, 2020
SELL
$71.87 - $131.03 $61.4 Million - $112 Million
-853,768 Reduced 69.21%
379,843 $28.9 Million
Q2 2020

Aug 14, 2020
BUY
$79.55 - $124.22 $96.7 Million - $151 Million
1,215,604 Added 6750.73%
1,233,611 $152 Million
Q1 2020

May 15, 2020
BUY
$71.37 - $96.85 $495,093 - $671,848
6,937 Added 62.66%
18,007 $1.52 Million
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $277,260 - $372,600
4,314 Added 63.85%
11,070 $936,000
Q3 2019

Nov 14, 2019
SELL
$67.4 - $85.11 $892,847 - $1.13 Million
-13,247 Reduced 66.23%
6,756 $455,000
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $285,483 - $333,626
3,553 Added 21.6%
20,003 $1.71 Million
Q1 2019

May 14, 2019
SELL
$84.2 - $98.62 $56.6 Million - $66.3 Million
-672,286 Reduced 97.61%
16,450 $1.46 Million
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $13.2 Million - $17.5 Million
-164,677 Reduced 19.3%
688,736 $58.6 Million
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $11.4 Million - $12.8 Million
-121,060 Reduced 12.42%
853,413 $82.8 Million
Q2 2018

Jul 19, 2018
BUY
$76.01 - $99.03 $3.03 Million - $3.95 Million
39,852 Added 4.26%
974,473 $91.8 Million
Q1 2018

May 10, 2018
SELL
$77.67 - $92.63 $6.94 Million - $8.28 Million
-89,411 Reduced 8.73%
934,621 $75.8 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $306,322 - $360,828
3,793 Added 0.37%
1,024,032 $91.3 Million
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $82.2 Million - $96.9 Million
1,020,239
1,020,239 $95 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email